M. Smirnov

发表

A Chimeric Protein C Containing the Prothrombin Gla Domain Exhibits Increased Anticoagulant Activity and Altered Phospholipid Specificity*

C. Esmon, N. Esmon, A. Rezaie, 1998, The Journal of Biological Chemistry.

On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies.

Naomi, Douglas, C. Esmon, 1995, The Journal of clinical investigation.

Antiphospholipid antibodies and the protein C pathway.

C. Esmon, N. Esmon, M. Smirnov, 2000, Journal of autoimmunity.

Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C.

C. Esmon, M. Smirnov, 1994, The Journal of biological chemistry.

Lipid Oxidation Enhances the Function of Activated Protein C*

C. Esmon, K. Hensley, N. Esmon, 2001, The Journal of Biological Chemistry.

Monoclonal antibodies that recognize trypsin binding domain of human urinary trypsin inhibitor.

M. Bauer, M. Smirnov, O. Ogloblina, 1993, Hybridoma.

Lupus anticoagulants, thrombosis and the protein C system.

C. Esmon, N. Esmon, M. Smirnov, 1999, Haematologica.

The effect of membrane composition on the hemostatic balance.

C. Esmon, D. Ford, N. Esmon, 1999, Biochemistry.

Lupus anticoagulants and thrombosis: the role of phospholipids.

C. Esmon, N. Esmon, M. Smirnov, 1997, Haematologica.

HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Inhibition of Activated Protein C Anticoagulant Activity by Prothrombin By

C. Esmon, N. Esmon, M. Smirnov, 1999 .

Experimentally Targeted Thrombolytic Therapy

A. Maksimenko, E. Tischenko, M. Smirnov, 1995 .

Low doses of activated protein C delay arterial thrombosis in rats.

A. Dobrovolsky, M. Smirnov, D. Borovikov, 1990, Thrombosis research.

Isolation and characterization of A protein C activator fromAgkistrodon contortrix contortrix venom

A. B. Dobrovol'skii, M. Smirnov, A. N. Storozhilova, 1989, Bulletin of Experimental Biology and Medicine.

Avidin attachment to biotinylated amino groups of the erythrocyte membrane eliminates homologous restriction of both classical and alternative pathways of the complement

V. Muzykantov, A. Klibanov, M. Smirnov, 1993, FEBS letters.

Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function*

C. Esmon, P. Liaw, P. Neuenschwander, 2000, The Journal of Biological Chemistry.

A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study.

A. Tripodi, M. Smirnov, O. Safa, 2007, Thrombosis research.

Thrombogenic Mechanisms of Antiphospholipid Antibodies

C. Esmon, N. Esmon, M. Smirnov, 1997, Thrombosis and Haemostasis.

HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Inhibition of Activated Protein C Anticoagulant Activity by Prothrombin By

C. Esmon, N. Esmon, M. Smirnov, 1999 .

Relocating the Active Site of Activated Protein C Eliminates the Need for Its Protein S Cofactor

C. Esmon, N. Esmon, A. Johnson, 1999, The Journal of Biological Chemistry.

[Effects of low doses of activated protein C in experimental arterial thrombosis in rats].

A. B. Dobrovol'skii, V. L. Golubykh, M. Smirnov, 1990, Kardiologiia.